Randomized trial · people

NMN did not improve grip strength or walking speed in 24 weeks

Checked against the paper Randomized trialPublished by PepVault

The takeaway

In this small human trial, NMN looked safe over 24 weeks but did not make older men with diabetes stronger or faster on their feet.

Kind
Randomized trial
Studied in
People
Number studied
14
Published
2023
Journal
Geriatr Gerontol Int

What they tested

The team tested whether taking NMN by mouth is safe and whether it improves grip strength and walking speed in older men with diabetes who had weak physical performance.

How the study was done

A randomized, double-blind, placebo-controlled trial in 14 men with diabetes, aged 65 or older (average age 81.1), who had low grip strength (under 26 kg) or slow walking speed (under 1.0 m/s). Over 24 weeks, the NMN arm took 250 mg/day and was compared with a placebo, a dummy pill.

A woman in glasses at a kitchen table with a laptop, a mug and her phone

PepVault for iPhone

Taking NMN? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

What they found

NMN was well tolerated, and no one had a severe side effect. Grip strength changed by 1.25 kg in the NMN group and by -0.44 kg in the placebo group. Walking speed changed by 0.033 m/s with NMN and by 0.014 m/s with placebo. Neither change differed between the groups, and none of the other measures differed either. Frailty became less common in the NMN group, and central retinal thickness changed differently between groups, but neither result reached statistical significance (P = 0.066 and P = 0.051).

What it doesn’t show

This was a very small trial of 14 men, all older and with diabetes, so it can't show whether NMN helps women, younger people or people without diabetes. At 24 weeks and one dose, it also can't show longer-term or dose-related effects.

The paper

Akasaka et al. Effects of nicotinamide mononucleotide on older patients with diabetes and impaired physical performance: A prospective, placebo-controlled, double-blind study. Geriatr Gerontol Int. 2023.

The compound

More studies on NMN

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.

Track it in the app

PepVault for iPhone

Taking NMN? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo